DVMTC PI, Thomas Denny, describes manufacturing accomplishments within the CIVICs Program.

Drs. Ted Ross and James Allen of CIVR-HRP describe how CIVICs enabled development of the COBRA HA mRNA vaccine candidate.

Dr. Drew Weissman of DCVC details how the CIVICs H1 HA mRNA-LNP vaccine candidate moved from the bench to the clinic.

Read about the vaccine candidates and human challenge studies developed and conducted by CIVICs investigators.

The CIVICs Network congratulates Dr. Shane Crotty, a SEM CIVIC investigator, on his election as a Councilor for the American Association of Immunologists (AAI).

Nature highlights research from each CIVICs Vaccine Research Center in their spotlight on development of a universal influenza vaccine.

American Association of Immunologists features CIVR-HRP vaccine research, which found variation in cellular immune responses across age groups.

Wiggins visited Dr. Andrea Sant’s lab to deepen her understanding of CD4+ T-cell responses to a COBRA-designed influenza vaccine candidate administered to obese mouse models.